NCT04897880 2025-02-24
NORTH
Australian & New Zealand Children's Haematology/Oncology Group
Phase 2 Terminated
Clinical Trials
4 trialsNCT03632317 2019-08-19
A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas
University of Michigan Rogel Cancer Center
Phase 2 Withdrawn
NCT01115036 2013-06-19
CLBH589C
Duke University
Phase 2 Withdrawn
NCT00848523 2010-07-16
Study of LBH589 (Panobinostat) to Treat Malignant Brain Tumors
Neurological Surgery, P.C.
Phase 2 Terminated